ve chronic lymphocytic leukemia
| Autor: | Banerji, V., Anglin, P., Christofides, A., Doucette, S., Laneuville, P. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Current Oncology Volume 27 Issue 2 Pages 6291-245 |
| ISSN: | 1718-7729 |
| DOI: | 10.3747/co.27.6291 |
| Popis: | The 2019 annual meeting of the American Society of Hematology took place 7&ndash 10 December in Orlando, Florida. At the meeting, results from key studies in treatment-naï ve chronic lymphocytic leukemia (cll) were presented. Of those studies, phase iii oral presentations focused on the efficacy and safety of therapy with inhibitors of Bruton tyrosine kinase (btk) and Bcl-2. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|